DCM
ZBH icon

Davis Capital Management’s Zimmer Biomet ZBH Stock Holding History

Davis Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$888 Buy
10
+1
+11% +$95 ﹤0.01% 527
2026
Q2 		$775 Buy
9
+7
+350% +$614 ﹤0.01% 531
2026
Q1 		$181 Sell
2
-2
-50% -$184 ﹤0.01% 558
2025
Q4 		$360 Buy
4
+2
+100% +$190 ﹤0.01% 462
2025
Q3 		$197 Buy
+2
New +$198 ﹤0.01% 575

Other funds holding ZBH

DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $145M AUM 29.71% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Davis Capital Management's ZBH Position: Q3 2026 in Review

Davis Capital Management increased its Zimmer Biomet (ZBH) stake by 11% in Q3 2026, buying an estimated $95 and bringing the position to 10 shares worth $888. The position accounts for ﹤0.01% of the portfolio, ranked #527.

Davis Capital Management first reported a position in ZBH in Q3 2025 and has held it in 5 quarters since. 28 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • Davis Capital Management held 10 shares of Zimmer Biomet worth $888 as of Q3 2026.
  • Davis Capital Management bought 1 Zimmer Biomet share in Q3 2026, an estimated $95.
  • Zimmer Biomet made up ﹤0.01% of Davis Capital Management's portfolio in Q3 2026, its #527 holding.
  • Davis Capital Management first reported a position in Zimmer Biomet in Q3 2025 and has held it in 5 quarters since.
  • 28 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.